Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Dr. Reddy's Laboratories Continues its Voluntary Nationwide Recall of Levetiracetam in 0.54% Sodium Chloride Injection 1500mg/100mL Due to Mislabeling


Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it’s wholly owned subsidiary, Dr Reddy’s Laboratories, Inc is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags to the hospital level in U.S.A. (US Food Recalls) More More

Similar stories

A Product Recall on Whole Cucumbers - Grocery.com

A Product Recall on Whole Cucumbers  Grocery.com

L&M Companies Inc. has announced a voluntary recall for its whole cucumber product due to a possible bacterial contamination. The recall was initiated after ...

Posted on 24 January 2017 | 3:00 am | Google News

Dr. Reddy's Expands Strategic Collaboration with Amgen in India - Business Wire

Dr. Reddy's Expands Strategic Collaboration with Amgen in India  Business Wire

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that it has expanded its strategic collaboration with Amgen, one.

Posted on 16 September 2016 | 2:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info